Utilization of disease modifying antirheumatic drugs (DMARDs) among patients with rheumatoid arthritis (RA).

被引：0
|
作者：
MacLean, CH
Park, GS
Traina, SB
Liu, HH
Hahn, BH
Paulus, HE
Kahn, KI
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
543
引用
收藏
页码：S143 / S143
页数：1
相关论文
共 50 条
  • [41] Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis in Medicare Managed Care Plans
    Schmajuk, Gabriela
    Trivedi, Amal N.
    Solomon, Daniel H.
    Yelin, Edward
    Trupin, Laura
    Chakravarty, Eliza F.
    Yazdany, Jinoos
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (05): : 480 - 486
  • [42] Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis
    Di Munno, O
    Delle Sedie, A
    Rossini, A
    Adamil, S
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (02) : 137 - 144
  • [43] Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis
    Aletaha, D
    Kapral, T
    Smolen, JS
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (05) : 482 - 486
  • [44] THE USE OF DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN THE MANAGEMENT OF RHEUMATOID-ARTHRITIS
    HART, LE
    TUGWELL, P
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1989, 65 (770) : 905 - 912
  • [45] Cost effectiveness analysis of disease modifying antirheumatic drugs in rheumatoid arthritis
    Manathip Osiri
    Pirom Kamolratanakul
    Andreas Maetzel
    Peter Tugwell
    [J]. Rheumatology International, 2007, 27 : 1063 - 1069
  • [46] TOXICITY PROFILES OF DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS
    SINGH, G
    FRIES, JF
    WILLIAMS, CA
    ZATARAIN, E
    SPITZ, P
    BLOCH, DA
    [J]. JOURNAL OF RHEUMATOLOGY, 1991, 18 (02) : 188 - 194
  • [47] Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis
    Rath, T.
    Sander, O.
    Rubbert, A.
    [J]. DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 657 - 663
  • [48] The Clinical Response to Biologic and Non-Biologic Disease Modifying Antirheumatic Drugs (DMARDs) According to Gender in a French-Canadian Population with Rheumatoid Arthritis (RA)
    Lagace, Sonia
    Bessette, Louis
    Coupal, Louis
    Choquette, Denis
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [49] Safety of biological disease-modifying antirheumatic drugs in rheumatoid arthritis
    Martinez-Mugica, Cristina
    Salgueiro, Esther
    [J]. FARMACIA HOSPITALARIA, 2022, 46 (01) : 15 - 20
  • [50] DEFINING THE TOXICITY OF DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS
    FURST, DE
    [J]. JOURNAL OF RHEUMATOLOGY, 1991, 18 (02) : 159 - 160
12345